Status and phase
Conditions
Treatments
About
This trial was designed to evaluate the efficacy and safety of SHR-1819 injection in patients with Prurigo Nodularis.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
236 participants in 4 patient groups, including a placebo group
Loading...
Central trial contact
Huiliu Wang
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal